Sponsors who implement QbD early can save money through increased product/process knowledge, less re-work, less product deviation, less product out-of-specification, fewer rejects and improved quality.
Authors:
Anil Kane, PhD, MBA, Executive Director, Global Head of Formulation Development, Patheon, by Thermo Fisher Scientific
Kaspar van den Dries, PhD, Senior Director and Principle Scientist Solid Dose Development, Patheon, by Thermo Fisher Scientific
Douglas Rufino, Vice President Global Corporate Quality, Pharmaceutical Development Services, Patheon, by Thermo Fisher Scientific
Resource Library